Response inhibition, the ability to withhold a dominant and prepotent response following a
change in circumstance or sensory stimuli, declines with advancing age. While non-invasive …

Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons in
the substantia nigra, the depletion of striatal dopamine and the presence of Lewy …

Objective: This study aimed to systematically review the effects of currently prescribed
antiparkinson medication on cognition in patients with mild-to-moderate Parkinson's disease …

A typical feature of Parkinson's disease (PD) is pathological activity in the subthalamic
nucleus (STN). Here, we tested whether in patients with PD under dopaminergic treatment …

Introduction Lower limb motor dysfunction is common in patients with stroke, and usually
caused by brain neural connectivity disorder. Previous studies have shown that the whole …

Aim The aim of this study was to assess the whole‐brain dynamic functional connectivity of
first‐episode and treatment‐naive patients with obsessive–compulsive disorder (OCD) and …

The phenomenon of impulsivity in Parkinson's disease appears as an arduous side effect of
dopaminergic therapy with potentially detrimental consequences for the life of the patients …

Antipsychotic intake may induce weight gain in drug-naive individuals with schizophrenia,
leading to poor compliance in clinical management. However, there is still a lack of effective …

Dopaminergic medications improve the motor symptoms of Parkinson's disease (PD), but
their effect on response inhibition, a critical executive function, remains unclear. Previous …

The neuroanatomical and molecular substrates for cognitive impairment in Parkinson
Disease (PD) are far from clear. Evidence suggests a non-dopaminergic basis, and a crucial …